Glenmark Pharma gains on plan to raise $500 million

29 Dec 2015 Evaluate

Glenmark Pharmaceuticals is currently trading at Rs. 926.80, up by 2.55 points or 0.28% from its previous closing of Rs. 924.25 on the BSE.

The scrip opened at Rs. 927.00 and has touched a high and low of Rs. 930.90 and Rs. 925.20 respectively. So far 8828 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 1261.95 on 21-Aug-2015 and a 52 week low of Rs. 703.50 on 07-Jan-2015.

Last one week high and low of the scrip stood at Rs. 957.80 and Rs. 917.00 respectively. The current market cap of the company is Rs. 26170.17 crore.

The promoters holding in the company stood at 46.45% while Institutions and Non-Institutions held 42.81% and 10.75% respectively.

Glenmark Pharmaceuticals is seeking shareholders’ approval to raise up to $500 million (around Rs 3,300 crore) by issue of securities in domestic and international markets.

In order to capitalise on various opportunities for further growth of the business, the company intends to enhance its marketing network both in domestic and overseas market, set up manufacturing infrastructure, focus on R&D and introduce new products across various markets.

Glenmark Pharma Share Price

1965.75 -8.40 (-0.43%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×